[
  {
    "ts": "2025-10-17T19:32:15+00:00",
    "headline": "Moderna Shares Fall After Early Trial Update on mRNA-4359 Cancer Vaccine Combination",
    "summary": "Moderna (MRNA) shares were down almost 5% in recent trading on Friday after management provided an u",
    "url": "https://finance.yahoo.com/news/moderna-shares-fall-early-trial-193215303.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "ae3892dd-e985-3788-9aec-dbc4fec554c5",
      "content": {
        "id": "ae3892dd-e985-3788-9aec-dbc4fec554c5",
        "contentType": "STORY",
        "title": "Moderna Shares Fall After Early Trial Update on mRNA-4359 Cancer Vaccine Combination",
        "description": "",
        "summary": "Moderna (MRNA) shares were down almost 5% in recent trading on Friday after management provided an u",
        "pubDate": "2025-10-17T19:32:15Z",
        "displayTime": "2025-10-17T19:32:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-shares-fall-early-trial-193215303.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-shares-fall-early-trial-193215303.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T13:59:15+00:00",
    "headline": "Moderna to Present Promising Phase 1/2 Clinical and Safety Data for Cancer Antigen Therapy mRNA-4359 at ESMO 2025",
    "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Moderna announced that promising clinical, safety, and translational data from its Phase 1/2 study evaluating the investigational immune-evasion targeted cancer antigen therapy/CAT mRNA-4359 would be presented at the 2025 European Society for Medical Oncology/ESMO […]",
    "url": "https://finance.yahoo.com/news/moderna-present-promising-phase-1-135915840.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "972b8318-310b-31bc-b3dd-28ae9ad8f28f",
      "content": {
        "id": "972b8318-310b-31bc-b3dd-28ae9ad8f28f",
        "contentType": "STORY",
        "title": "Moderna to Present Promising Phase 1/2 Clinical and Safety Data for Cancer Antigen Therapy mRNA-4359 at ESMO 2025",
        "description": "",
        "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Moderna announced that promising clinical, safety, and translational data from its Phase 1/2 study evaluating the investigational immune-evasion targeted cancer antigen therapy/CAT mRNA-4359 would be presented at the 2025 European Society for Medical Oncology/ESMO […]",
        "pubDate": "2025-10-17T13:59:15Z",
        "displayTime": "2025-10-17T13:59:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Moderna to Present Promising Phase 1/2 Clinical and Safety Data for Cancer Antigen Therapy mRNA-4359 at ESMO 2025",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1_dbUZV6cAq6Zm3QVCmGdw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6tuqwu6weMIqVwqkD1gIVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-present-promising-phase-1-135915840.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-present-promising-phase-1-135915840.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]